HAOXI HEALTH TEC. LTD.

Haoxi Health Technologie completed a registered direct placement of about $4 million, selling 10 million Class A common shares at $0.40 each. Alternatively, the company offered prepaid warrants at the same purchase price with an exercise price of $0.33. The capital raise comes as the stock trades at $0.27 after a 67% decline and the market capitalization is only about $0.8 million, making the financing important for ongoing operations. Univest Securities acted as sole placement agent; the transaction was conducted under an F-3 shelf registration that the SEC declared effective. » More on de.investing.com

Haoxi Health Technology announced a registered direct placement of 10,000,000 Class A shares at $0.40 each and is offering, as an alternative, pre-funded warrants at the same purchase price with an exercise price of $0.33. The transaction is expected to generate roughly $4 million in gross proceeds and is anticipated to close around July 13, 2026, subject to customary conditions. The offer price is substantially below the current share price of $0.89; the company is reportedly burning cash quickly. Univest Securities is acting as sole placement agent; the placement is being made under a shelf registration on Form F-3. » More on de.investing.com

Haoxi Health Technologie has announced the convening of an extraordinary general meeting and filed the related notice and proxy materials with the SEC. The board and senior executives may assist in soliciting proxies. Information on directors, executive officers and related interests is included in the materials; copies are available on the SEC’s website and the company’s website. The filing was signed by Zhen Fan, Chief Executive Officer and Chairman. » More on de.investing.com